Britain has approved the sale of lab-grown meat for pet food, marking a significant step forward in the biotech industry. The approval, which positions Britain as a pioneer in this field within Europe, has opened doors for innovative entrepreneurs post-Brexit.
Meatly: Leading the Way
Meatly, a British company specializing in growing meat from chicken cells, has received the landmark approval for its lab-grown pet food product. The company is set to commence feeding trials in August, showcasing a product that offers a sustainable and animal-friendly alternative to traditional pet food.
The Future of Pet Food Industry
The approval of lab-grown meat for pet food comes at a time when the global pet food market is on the rise, with an expected growth of 5% to reach $151 billion this year, according to Statista. Meatly’s innovative approach aims to meet the nutritional needs of pets while satisfying their cravings for meat.
Benefits of Lab-Grown Meat
According to Owen Ensor, the CEO of Meatly, lab-grown meat offers a solution that combines the satisfaction of feeding pets meat with the nutritional requirements necessary for their well-being. Ensor himself has fed the product to his own cats, Lamu and Zanzi, emphasizing its quality and benefits.
Regulatory Advantage for Britain
Britain’s position as a frontrunner in lab-grown meat approval is attributed to its independence from the European Union’s stringent regulations. Advocates of alternative proteins highlight that the U.K.’s streamlined regulatory system post-Brexit allows for faster approval of technological advancements like lab-grown meat, positioning the country at the forefront of innovation in this sector.
